$10.17
-0.20 (-1.93%)
Enzon Pharmaceuticals, Inc. (ENZN)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

RSS Headlines
Fool UK